Aikeda Bio
Innovating the future of diagnostic systems with comprehensive solutions in coagulation, specific protein, reproductive, and immune detection.
Innovating the future of diagnostic systems with comprehensive solutions in coagulation, specific protein, reproductive, and immune detection.
Aikeda Bio is a innovative startup in the Health Care industry, founded in 2017. The company focuses on innovating the future of diagnostic systems with comprehensive solutions in coagulation, specific protein, reproductive, and immune detection. Aikeda Bio provides R&D production, sales, and technical services in its product offerings, which include coagulation detection systems, specific protein detection systems, reproductive detection systems, and immune detection systems. The latest milestone for Aikeda Bio was the Series A investment at 01 September 2023, with investments coming from Addor Capital, Shandong New Growth Drivers Fund, and CITIC Medical Fund. This recent investment may further fuel the company's growth and innovation in the field of diagnostic systems, enhancing its potential for impactful contributions to the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | Unknown | 3 |
|
01 Sep 2023 |
No recent news or press coverage available for Aikeda Bio.
We care about your data, and we'd love to use cookies make your experience better.